Literature DB >> 10598588

Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2.

W Xie1, H Hong, N N Yang, R J Lin, C M Simon, M R Stallcup, R M Evans.   

Abstract

In this report, we demonstrate that, in contrast to most previously characterized nuclear receptors, hERR1 and hERR2 (human estrogen receptor-related protein 1 and -2) are constitutive activators of the classic estrogen response element (ERE) as well as the palindromic thyroid hormone response element (TRE(pal)) but not the glucocorticoid response element (GRE). This intrinsically activated state of hERR1 and hERR2 resides in the ligand-binding domains of the two genes and is transferable to a heterologous receptor. In addition, we show that members of the p160 family of nuclear receptor coactivators, ACTR (activator of thyroid and retinoic acid receptors), GRIP1 (glucocorticoid receptor interacting protein 1), and SRC-1 (steroid receptor coactivator 1), potentiate the transcriptional activity by hERR1 and hERR2 in mammalian cells, and that both orphan receptors bind the coactivators in a ligand-independent manner. Together, these results suggest that hERR1 and hERR2 activate gene transcription through a mechanism different from most of the previously characterized steroid hormone receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598588     DOI: 10.1210/mend.13.12.0381

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  45 in total

1.  Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression.

Authors:  Daigo Sumi; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

2.  4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma.

Authors:  P Coward; D Lee; M V Hull; J M Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  Production and characterization of monoclonal antibodies to estrogen-related receptor alpha (ERRα) and use in immunoaffinity chromatography.

Authors:  Amanda M Esch; Nancy E Thompson; Jennifer A Lamberski; Janet E Mertz; Richard R Burgess
Journal:  Protein Expr Purif       Date:  2012-05-04       Impact factor: 1.650

4.  LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1.

Authors:  Taiga Suzuki; Megumi Kasahara; Hidefumi Yoshioka; Ken-Ichirou Morohashi; Kazuhiko Umesono
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 5.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

Review 6.  Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nat Rev Cancer       Date:  2012-11-29       Impact factor: 60.716

7.  Molecular cloning, expression, and stress response of the estrogen-related receptor gene (AccERR) from Apis cerana cerana.

Authors:  Weixing Zhang; Ming Zhu; Ge Zhang; Feng Liu; Hongfang Wang; Xingqi Guo; Baohua Xu
Journal:  Naturwissenschaften       Date:  2016-02-27

8.  Cloning and developmental expression of five estrogen-receptor related genes in the zebrafish.

Authors:  Pierre-Luc Bardet; Sophie Obrecht-Pflumio; Christine Thisse; Vincent Laudet; Bernard Thisse; Jean-Marc Vanacker
Journal:  Dev Genes Evol       Date:  2004-04-16       Impact factor: 0.900

9.  Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression.

Authors:  Debbie L C van den Berg; Wensheng Zhang; Adam Yates; Erik Engelen; Katalin Takacs; Karel Bezstarosti; Jeroen Demmers; Ian Chambers; Raymond A Poot
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

10.  The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα.

Authors:  Susan M Krzysik-Walker; Isabel González-Mariscal; Morten Scheibye-Knudsen; Fred E Indig; Michel Bernier
Journal:  Mol Pharmacol       Date:  2012-10-12       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.